XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Share-Based Compensation Plans (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Compensation Plans  
Schedule of stock option activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

Weighted

​

Average

​

​

​

​

​

​

​

Average

​

Remaining

​

Aggregate

​

​

​

​

Exercise

​

Contractual

​

Intrinsic

​

    

Shares

    

Price

    

Term (Years)

    

Value*

Outstanding at December 31, 2023

 

967,217

​

$

26.22

 

  

 

​

  

Granted

 

—

​

​

—

 

  

 

​

  

Exercised

 

(105,072)

​

​

24.64

 

  

 

​

  

Forfeited or expired

 

(11,680)

​

​

25.76

 

  

 

​

  

Outstanding at September 30, 2024

 

850,465

​

$

26.41

 

6.1

​

$

6,851,000

Exercisable at September 30, 2024

 

567,574

​

$

26.88

 

5.2

​

$

4,426,000

​

*The aggregate intrinsic value of outstanding and exercisable stock options is defined as the difference between the market value of our common stock on September 30, 2024 of $34.04 and the exercise price multiplied by the number of in-the-money outstanding and exercisable stock options.

Schedule of restricted stock award activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

    

​

​

    

​

​

​

​

​

​

​

​

​

​

Weighted 

​

​

​

​

​

​

​

​

Weighted

​

Average

​

​

​

​

​

​

Shares of

​

 Average

​

Remaining

​

​

Aggregate

​

​

​

Restricted

​

Grant Date

​

Contractual

​

​

Intrinsic

​

​

​

Stock

​

Fair Value

​

Term (Years)

​

​

Value*

​

Non-vested - December 31, 2023

 

69,090

​

$

25.54

​

​

​

​

​

​

​

Issued

 

54,855

​

 

34.65

​

 

​

​

 

​

​

Vested

 

(30,255)

​

 

24.86

​

 

​

​

 

​

​

Forfeited

 

(625)

​

 

27.86

​

 

​

​

 

​

​

Non-vested - September 30, 2024

 

93,065

​

$

31.12

​

3.8

​

​

$

3,168,000

​

​

*The aggregate intrinsic value of non-vested restricted stock was calculated using the market value of our common stock on September 30, 2024 of $34.04 multiplied by the number of non-vested restricted shares outstanding.